| Direct Competitor Comparison | |
|---|
| GSK | MRK | NVS | PFE | Industry |
|---|
| Market Cap: | 127.74B | 144.34B | 180.09B | 206.84B | 64.52B |
|---|
| Employees: | 99,488 | 83,000 | 129,000 | 89,400 | 99.49k |
|---|
| Qtrly Rev Growth (yoy): | -0.03 | -0.09 | 0.02 | -0.09 | 0.11 |
|---|
| Revenue (ttm):
| 42.21B | 46.21B | 57.80B | 57.60B | 27.01B |
|---|
| Gross Margin (ttm): | 0.71 | 0.65 | 0.68 | 0.81 | 0.61 |
|---|
| EBITDA (ttm): | 14.49B | 16.36B | 17.15B | 25.34B | 10.37B |
|---|
| Operating Margin (ttm):
| 0.28 | 0.21 | 0.22 | 0.32 | 0.16 |
|---|
| Net Income (ttm): | 6.78B | 6.02B | 9.66B | 10.52B | N/A |
|---|
| EPS (ttm): | 2.74 | 1.96 | 3.94 | 2.09 | 3.27 |
|---|
| P/E (ttm): | 19.28 | 24.39 | 18.60 | 13.96 | 14.20 |
|---|
| PEG (5 yr expected): | 4.12 | 4.51 | 2.61 | 4.82 | 0.96 |
|---|
| P/S (ttm): | 3.03 | 3.12 | 3.12 | 3.59 | 2.23 |
|---|
|
| MRK = Merck & Co. Inc. | | NVS = Novartis AG | | PFE = Pfizer Inc. | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 99.08 | 0.00 | 74.31B | 16.77 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 207.75 | 0.00 | 49.31B | 32.97 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 51.03 | 0.00 | 77.84B | 28.57 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 74.24 | 0.00 | 12.77B | 31.43 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.32 | 0.00 | 33.50B | 19.63 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 124.94 | 0.00 | 15.96B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.54 | 0.00 | 12.02B | 21.07 |
|---|
| Pfizer Inc. | PFE | 29.16 | 0.00 | 206.84B | 13.96 |
|---|
| Johnson & Johnson | JNJ | 85.63 | 0.00 | 240.52B | 23.26 |
|---|
| GlaxoSmithKline plc | GSK | 52.74 | 0.00 | 127.74B | 19.28 |
|---|
| Sanofi | SNY | 55.02 | 0.00 | 145.62B | 27.12 |
|---|
| Novartis AG | NVS | 73.29 | 0.00 | 180.09B | 18.60 |
|---|
| Roche Holding AG | RHHBY | 62.44 | 0.00 | 211.91B | 20.90 |
|---|
| AstraZeneca PLC | AZN | 50.97 | 0.00 | 63.71B | 11.27 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.89 | 0.00 | 57.51B | 11.24 |
|---|
| Bristol-Myers Squibb Company | BMY | 46.44 | 0.00 | 76.28B | 52.59 |
|---|
|
| News on Direct Competitors | |
|---|
No Direct Competitor ComparisionCurrency in USD. | |
|
0.38%